🔗 Share this article

A shadow market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and sellers on messaging platforms, based on recent findings.

Investigational Drug Gaining Traction Online

The experimental drug, which remains in research studies, is being advertised by online personalities for its supposed weight-reducing effects. Viewers are urged to contact these profiles directly for supplier links, while also obtaining discount codes.

Active Trade on Social Networks

Separately, a flourishing trade exists on Telegram, where communities with numerous of members share “before and after” photos, administration instructions and assertions of rapid British shipping. Sellers market the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help individuals lose up to 25% of their total weight. Nicknamed the “triple G”, the drug is being hailed online as the successor to Ozempic.

Medical Professionals Express Concerns

However, doctors and pharmacists have warned that the distribution of what is still an unlicensed drug in the UK is a cause for concern and could lead to users administering substances of uncertain source.

Some professionals stated the popularity for retatrutide could be connected to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Several influencers attempt to circumvent the regulations by referring to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach medicines, advertising, and consumer regulations, risking fines, legal action or imprisonment.

Service Reaction and Material Elimination

According to the social media company, the platform has taken down problematic material and prohibited associated keywords and query recommendations. The organization stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using the platform's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, filled with images of slimming results, glowing reviews and detailed guides for preparing or administering at home.

Within moments of joining one community, a seller shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and promised delivery within 48 hours. When asked whether the product was authentic, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or past usage.

Product Details and Pricing

Inside these groups, messages display dark colored parcels with postal service labels, stating to contain new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20 milligrams. When questioned how long a pen should last, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it regularly moderated dangerous material on its service including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to recent cost increases for approved weight-loss drugs such as Mounjaro. “With costs increasing, patients are using social media. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the frustration, but buying from messaging apps or WhatsApp is gambling with your well-being,” stated Wyllie. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said the substance was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “misleadingly claiming itself as a Lilly investigational substance not yet approved … may expose users to potentially serious medical dangers”.